OPL Cares about Human Health
The World Benefits from OPL’s Technology
Powered by our proprietary timed-release technologies, OPL is a leader to develop NDA products under 505(b)(2) regulatory pathway and to extend patent protection of existing products and improve drugability of NCEs.
Through a strategic focus on portfolio management, we unlock greater value by enhancing efficacy and safety, improving patient compliance, extending IP protection, and enabling differentiated combination products.
From innovative R&D to commercialization, our expertise in oral solid timed-release technologies-along with emerging capabilities in oral peptide delivery-delivers high-performance solutions that drive lasting clinical and commercial success.
Founded in 2011 with three location based in San Diego, US and Guangzhou and Taizhou, China OPL has 80+ employees and 150,000 s.q. feet facility including R&D, pilot plant and GMP facility with DEA and FDA license of controlled substance.
To become a world leader in developing proprietary drug delivery technologies and in developing NDA products under 505(b)(2) regulatory pathway.
To deliver value added products which are safer, more efficacious and better patient compliance to meet the unmet clinical needs.
Patient-first, Innovation, Responsibility, Integrity.
Provide new drug products to improve quality of life. Provide financial return for the stock holders. Provide a platform for employees to realize their dreams of developing new drug products. Provide financial freedom for employees to raise their families.
Find ways to success. Makes no excuses for failure.
OPL cares about human health. World benefits from OPL's technology.
CEO
Founder and Chairman of the Board
Chief Strategy Officer
Head, Innovation Center
Clinical Director
R&D Director
Medical Director
CEO
Founder and Chairman of the Board
Chief Strategy Officer
Head, Innovation Center
Clinical Director
R&D Director
Medical Director
Approved by FDA
Approved by NMPA
Approved by FDA
Approved by NMPA
Approved by FDA
Approved by NMPA
Address：Suite 201, Building C1, #11 Kaiyuan Avenue, Huangpu District, Guangzhou City, Guangdong Province, P.R.China 510700
Building G106 Phase 5, China Medical City, HIGH-TECH Zone, Taizhou City, Jiangsu Province,P.R.225300
6323 Nancy ridge Drive San Diego California USA 92121
Tel：+86-20-31600402（Guangzhou）
+86-523-86813669（Taizhou）
+1-(650)3889210（USA）
E-mail：contact@overseaspharm.com
